Education
About Us
Working with TipRanks
Follow Us
Colossal Biosciences
Leadership & Board
Key Executives
Co-Founder and CEOBen Lamm
Co-Founder & Chief Business OfficerPeter Phillips
Co-Founder + COOKent Wakeford
VP of StrategyAlexander Titus
Current Number of Employees244
Current LinkedIn Followers50,767
Latest Estimated Valuation
Estimated Valuation$10B
Estimated Valuation$10B
Total Amount Raised$120M
Total Amount Raised$120M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$120M
Latest Funding Amount$120M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation$10B
Post-Money Valuation$10B
Company Momentum Positive
Articles Published on TipRanks3
Articles Published on TipRanks
3
LinkedIn Trend+0.29% followers
LinkedIn Trend
+0.29% followers
Workforce Trend+0.0% employees
Workforce Trend
+0.0% employees
Colossal Biosciences LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.
Employee Trend
Colossal Biosciences had 244 employees as of March 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
244Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Colossal Biosciences had 50,767 followers as of March 16, 2026. The number of followers increased by 148 (0.29%) week-over-week.
50,767Latest Followers Count
148(0.29%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Sep 17, 2025
Series C
$120.00M
$10.32B
